Mercy's Dr. Jennifer Joh Addresses Triple Negative Breast Cancer
January 02, 2018
A breast cancer diagnosis can be complex. There are varying types of the disease.
Breast cancer that is not supported by the hormones estrogen and progesterone nor by the presence of too many HER-2 receptors is called triple negative. It's more rare and does not respond to typical breast cancer medicines.
According to dedicated breast surgeon Dr. Jennifer Joh of The Hoffberger Breast Center at Mercy Medical Center, there is tremendous research happening right now.
"Triple negative breast cancer is a very hot topic because we don't really have great ways of treating the breast cancer, and it does tend to be more aggressive and it does tend to lead to reduced survival rates," Dr. Joh said.
Triple negative accounts for just 10 to 20 percent of breast cancer cases and is more common in young women, African-Americans, Hispanics and those with the BRCA1 gene mutation.
To view Dr. Jennifer Joh’s interview regarding triple negative breast cancer, click here.
About Mercy
Founded in 1874 in Downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed, acute care, university-affiliated teaching hospital. Mercy has been recognized as a high-performing Maryland hospital (U.S. News & World Report); has achieved an overall 5-Star quality, safety, and patient experience rating (Centers for Medicare and Medicaid Services); is A-rated for Hospital Safety (Leapfrog Hospital Safety Grade); and is certified by the American Nurses Credentialing Center as a Magnet™ hospital. Mercy Health Services is a not-for-profit health system and the parent company of Mercy Medical Center and Mercy Personal Physicians.
Media Contact
Dan Collins, Senior Director of Media Relations
Office: 410-332-9714
Cell: 410-375-7342
Email: dcollins@mdmercy.com